PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
34363189-7	2021	Clarithromycin use was associated with decreases in circulating C-reactive protein, tumour necrosis factor-alpha and interleukin (IL)-6; by increase of production of interferon-gamma and decrease of production of interleukin-6 by mononuclear cells; and by suppression of SARS-CoV-2 viral load.	Clarithromycin	0-14	C-reactive protein	Homo sapiens	64-82	
22687800-2	2012	Subsequently she received four weeks of oral levofloxacin and eight weeks of oral clarithromycin due to persistent elevation of C-reactive protein.	Clarithromycin	82-96	C-reactive protein	Homo sapiens	128-146	
33552084-7	2020	In this model, the combination of E-CRP and clarithromycin drastically reduced bacteremia and increased survival of mice when compared to the protective effects of either E-CRP or clarithromycin alone.	Clarithromycin	180-194	C-reactive protein	Homo sapiens	36-39